ATAI

ATAI Life Sciences N.V.

1.21 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

ATAI Life Sciences N.V. stock is up 3.42% since 30 days ago. The next earnings date is Mar 22, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 2 December’s closed higher than November.

About ATAI Life Sciences N.V.

Atai Life Sciences N.V. operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression (TRD)